Skip to main content
. 2018 Jun 7;20(6):54. doi: 10.1007/s11906-018-0863-1

Fig. 1.

Fig. 1

Hypertension clinical, therapeutic and genomic timeline. Current hypertension pharmacotherapy whilst not informed by genomics does target many of the pathways involved in monogenic BP syndromes. The timeline highlights the potential of the modern genomics era for discovery of novel pathways and new drugs for hypertension